Article
Differential Prognostic Value of Vascular Invasion in Resected Lung Adenocarcinomas According to Epidermal Growth Factor Receptor Mutational Status.
Clinical lung cancer - 1 Nov 2023
Lee Kyung Hee, Chung Jin-Haeng, Cho Sukki, Lee Jong-Seok, Kim Hyungjin
Abstract excerpt
BACKGROUND: It is unclear whether all patients with stage IB to IIIA epidermal growth factor receptor (EGFR)-mutant adenocarcinoma should receive adjuvant osimertinib. We investigated the prognostic value of vascular invasion for risk stratification according to EGFR mutational status. MATERIALS AND METHODS: This retrospective study evaluated patients with stage IB to IIIA lung adenocarcinoma resected between...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
